Shoichi Uezono

Shoichi Uezono

Auto-generated profile, based on publicly available information

Shoichi Uezono

Affiliation Department of Anesthesiology, The Jikei University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Best Practice & Research Clinical Anaesthesiology
Verified
Journal Article
Closed access
SUShoichi Uezono
Shoichi Uezono
YMYasushi Mio
Yasushi Mio

1 December 2002 in Sleep Medicine
Verified
Journal Article
Closed access
SUShoichi Uezono
Shoichi Uezono
AKAya Kamata
Aya Kamata
ONOsamu Nagata
Osamu Nagata
MOMakoto Ozaki
Makoto Ozaki

11 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKaoru Suzuki
Kaoru Suzuki
HSHiroshi Sunaga
Hiroshi Sunaga
KYKentaro Yamakawa
Kentaro Yamakawa
YSYoshifumi Suga
Yoshifumi Suga
IKIchiro Kondo
Ichiro Kondo
SUShoichi Uezono
Shoichi Uezono
Background: Neuromuscular blocking agents induce muscle paralysis via the prevention of synaptic transmission at the neuromuscular junction and may have additional effects at other sites of action. With regard to potential effects of neuromuscular blocking agents on the central nervous system, a definitive view has not been established. We investigated whether intravenous infusion of rocuronium bromide affects the emergence from propofol anesthesia. Methods: Using an in vivo rat model, we performed propofol infusion for 60 minutes, along with rocuronium bromide at various infusion rates or normal saline. Sugammadex or normal saline was injected at the end of the infusion period, and we evaluated the time to emergence from propofol anesthesia. We also examined the neuromuscular blocking, circulatory, and respiratory properties of propofol infusion along with rocuronium bromide infusion to ascertain possible factors affecting emergence. Results: Intravenous infusion of rocuronium bromide dose-dependently increased the time to emergence from propofol anesthesia. Sugammadex administered after propofol infusion not containing rocuronium bromide did not affect the time to emergence. Mean arterial pressure, heart rate, partial pressures of oxygen and carbon dioxide, and pH were not affected by rocuronium bromide infusion. Neuromuscular blockade induced by rocuronium bromide, even at the greatest infusion rate in the emergence experiment, was rapidly antagonized by sugammadex. Conclusions: These results suggest that intravenous infusion of rocuronium bromide dose-dependently delays the emergence from propofol anesthesia in rats. Future studies, such as detection of rocuronium in the cerebrospinal fluid or central nervous system, electrophysiologic studies, microinjection of sugammadex into the brain, etc., are necessary to determine the mechanism of this effect.

20 September 2017 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
IKIchiro Kondo
Ichiro Kondo
HKHidetsugu Kobayashi
Hidetsugu Kobayashi
YSYoshihumi Suga
Yoshihumi Suga
ASAkihiro Suzuki
Akihiro Suzuki
SKShuya Kiyama
Shuya Kiyama
SUShoichi Uezono
Shoichi Uezono

1 June 1999 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
TGTakahisa Goto
Takahisa Goto
YNYoshinori Nakata
Yoshinori Nakata
SUShoichi Uezono
Shoichi Uezono
YNYoshinari Niimi
Yoshinari Niimi
MUMasanori Uchiyama
Masanori Uchiyama
SMShigeho Morita
Shigeho Morita

1 June 2011 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
THT. Hascilowicz
T. Hascilowicz
THT. Hamaguchi
T. Hamaguchi
SNS. Nakata
S. Nakata
YYY. Yamamoto
Y. Yamamoto
SKS. Kiyama
S. Kiyama
SUS. Uezono
S. Uezono